@article{beb12b0dc501437f889509150a59342e,
title = "Saudi Heart Association (SHA) guidelines for the management of heart failure",
abstract = "Heart failure (HF) is the leading cause of morbidity and mortality worldwide and negatively impacts quality of life, healthcare costs, and longevity. Although data on HF in the Arab population are scarce, recently developed regional registries are a step forward to evaluating the quality of current patient care and providing an overview of the clinical picture. Despite the burden of HF in Saudi Arabia, there are currently no standardized protocols or guidelines for the management of patients with acute or chronic heart failure. Therefore, the Heart Failure Expert Committee, comprising 13 local specialists representing both public and private sectors, has developed guidelines to address the needs and challenges for the diagnosis and treatment of HF in Saudi Arabia. The ultimate aim of these guidelines is to assist healthcare professionals in delivering optimal care and standardized clinical practice across Saudi Arabia.",
keywords = "Acute heart failure, Chronic heart failure, Heart failure recommendations, Multidisciplinary management, Saudi Arabia",
author = "Waleed AlHabeeb and F. Al-Ayoubi and K. AlGhalayini and {Al Ghofaili}, F. and {Al Hebaishi}, Y. and Abdulrazaq Al-Jazairi and Al-Mallah, {Mouaz H.} and Ali AlMasood and {Al Qaseer}, Maryam and Shukri Al-Saif and A. Chaudhary and Abdelfatah Elasfar and Adel Tash and Mohamed Arafa and W. Hassan",
note = "Funding Information: All arrangements for consensus generation such as meeting arrangements, travel, and follow-up were conducted by the SHA. Although the consensus meeting (held on October 7–8, 2016, in Riyadh, Saudi Arabia), and the medical writing was funded by Novartis through a research grant [SA1610535252], Novartis played no direct role in the collection, analysis, and interpretation of data or in the preparation of this manuscript. Dr. Waleed AlHabeeb has received speaker honoraria from Novartis, Pfizer, Merck, MSD, Bayer, and Servier. Yahya Al Hebaishi has received speaker honoraria from Pfizer and Bayer. Mouaz H. Al-Mallah has received speaker honoraria from GE Healthcare. Ali AlMasood has received speaker honoraria from Novartis. Maryam Al Qaseer has received speaker honoraria from Novartis and Bayer. Shukri Al-Saif has received speaker honoraria from Merck and AstraZeneca, and is a clinical investigator for Novartis-sponsored research. Ammar Chaudhary has received speaker honoraria from Novartis. Fakhr Al-Ayoubi, Kamal AlGhalayini, Fahad Al Ghofaili, Abdulrazaq Al-Jazairi, Abdelfatah Elasfar, Adel Tash, Mohamed Arafa, and Walid Hassan have no conflicts of interest to declare. Funding Information: This project is supported by the Saudi Heart Association and funded through a research grant from Novartis , Riyadh, Saudi Arabia (Grant No. SA1610535252 ). Medical writing support was provided by Leris D{\textquoteright}Costa of OPEN Health , and funded through a research grant issued to the Saudi Heart Association by Novartis, Riyadh, Saudi Arabia (Grant No. SA1610535252 ). Funding Information: This project is supported by the Saudi Heart Association and funded through a research grant from Novartis, Riyadh, Saudi Arabia (Grant No. SA1610535252). Medical writing support was provided by Leris D'Costa of OPEN Health, and funded through a research grant issued to the Saudi Heart Association by Novartis, Riyadh, Saudi Arabia (Grant No. SA1610535252). This manuscript has been written by the Saudi Heart Failure Working Group, of the Saudi Heart Association. Dr. Waleed AlHabeeb, President of the Saudi Heart Failure Working Group, of the SHA, and lead author of the manuscript was actively involved in the conception and execution of this project. All authors are board members of the Saudi Heart Failure Working Group, of the Saudi Heart Association, and have actively participated in recommendation generation. The final manuscript was approved by the board of the Saudi Heart Association. Waleed AlHabeeb, Fakhr Al-Ayoubi, Kamal AlGhalayini, Fahad Al Ghofaili, Yahya Al Hebaishi, Abdulrazaq Al-Jazairi, Mouaz H. Al-Mallah, Ali AlMasood, Maryam Al Qaseer, Shukri Al-Saif, Ammar Chaudhary, Abdelfatah Elasfar, and Adel Tash participated in the premeeting survey and conducted literature review in support of the recommendations; participated in the consensus meeting for generating recommendations for management of HF in Saudi Arabia; and contributed to the development, review, and finalization of the manuscript. Mohamed Arafa and Walid Hassan were responsible for overall critical review of the recommendations and manuscript content. All authors approved the submitted version of the manuscript. All arrangements for consensus generation such as meeting arrangements, travel, and follow-up were conducted by the SHA. Although the consensus meeting (held on October 7?8, 2016, in Riyadh, Saudi Arabia), and the medical writing was funded by Novartis through a research grant [SA1610535252], Novartis played no direct role in the collection, analysis, and interpretation of data or in the preparation of this manuscript. Dr. Waleed AlHabeeb has received speaker honoraria from Novartis, Pfizer, Merck, MSD, Bayer, and Servier. Yahya Al Hebaishi has received speaker honoraria from Pfizer and Bayer. Mouaz H. Al-Mallah has received speaker honoraria from GE Healthcare. Ali AlMasood has received speaker honoraria from Novartis. Maryam Al Qaseer has received speaker honoraria from Novartis and Bayer. Shukri Al-Saif has received speaker honoraria from Merck and AstraZeneca, and is a clinical investigator for Novartis-sponsored research. Ammar Chaudhary has received speaker honoraria from Novartis. Fakhr Al-Ayoubi, Kamal AlGhalayini, Fahad Al Ghofaili, Abdulrazaq Al-Jazairi, Abdelfatah Elasfar, Adel Tash, Mohamed Arafa, and Walid Hassan have no conflicts of interest to declare. Publisher Copyright: {\textcopyright} 2019 King Saud University",
year = "2019",
month = oct,
doi = "10.1016/j.jsha.2019.06.004",
language = "English (US)",
volume = "31",
pages = "204--253",
journal = "Journal of the Saudi Heart Association",
issn = "1016-7315",
publisher = "Saudi Heart Association",
number = "4",
}